Valeant Providing Reporters With an Earnings Metric the SEC Ordered it to Stop Using Post author:Sam Post published:November 9, 2017 Post category:BioPharma Valeant is not the only company to recently push reporters to defy the SEC’s orders. Source: BioSpace You Might Also Like Tiny Virtual Biotech CellAct Forges $250 Million Chemo R&D Pact With Mundipharma August 13, 2017 Ex-Google Rock Star Decides to Raise $100 Million Biotech Venture Fund After All March 14, 2017 How Artificial Life Spawned A Billion-Dollar Industry April 5, 2017
